Drug profile · INN
autologous cd34+ cells encoding arsa gene
LIBMELDY
autologous cd34+ cells encoding arsa gene (LIBMELDY) is a arsa exogenous gene.
EMA: approved Nervous system (N07) N07
Patents linked 0
Pipeline programs 3
News articles 0
Drug details — autologous cd34+ cells encoding arsa gene
- Class
- Nervous system (N07)
- Route
- —
- Patents
- 0
- Programs
- 3
- Data quality
- 0.83
Quick answer
autologous cd34+ cells encoding arsa gene (LIBMELDY) is a arsa exogenous gene.
Key facts
INN autologous cd34+ cells encoding arsa gene
Brand LIBMELDY
Mechanism ARSA exogenous gene
Target ARSA
Therapeutic class Nervous system (N07)
ATC code N07
Mechanism of action
ARSA exogenous gene
Primary target: ARSA
Approval history
| Authority | Status | Date |
|---|---|---|
| EMA | approved | — |
Pipeline programs
Related & competitor drugs
Frequently asked questions
What is autologous cd34+ cells encoding arsa gene?
autologous cd34+ cells encoding arsa gene (LIBMELDY) is a arsa exogenous gene.
What is the brand name for autologous cd34+ cells encoding arsa gene?
LIBMELDY is a marketed brand name for autologous cd34+ cells encoding arsa gene. Check FDA Drugs@FDA for the current US label holder and prescribing information.